UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Arkadios Wealth Advisors

Arkadios Wealth Advisors trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,719 shares of the healthcare conglomerate's stock after selling 1,601 shares during the quarter. Arkadios Wealth Advisors' holdings in UnitedHealth Group were worth $4,916,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates grew its stake in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock valued at $31,000 after buying an additional 32 shares in the last quarter. West Financial Advisors LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $32,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the third quarter worth about $37,000. Finally, Quarry LP boosted its stake in shares of UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock valued at $33,000 after purchasing an additional 37 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH traded down $0.56 during trading hours on Friday, reaching $510.03. The company had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a 50 day simple moving average of $549.37 and a 200-day simple moving average of $563.18. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market capitalization of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company's revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.83 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group's payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on UNH shares. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a research report on Wednesday, October 16th. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Bank of America lowered their price objective on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. StockNews.com cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Wednesday. Finally, KeyCorp reiterated an "overweight" rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.